612 related articles for article (PubMed ID: 9460988)
1. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
Acevedo CM; Henríquez M; Emmert-Buck MR; Chuaqui RF
Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
[TBL] [Abstract][Full Text] [Related]
3. Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma.
Mugica-Van Herckenrode C; Rodriguez JA; Iriarte-Campo V; Carracedo A; Barros F
Diagn Mol Pathol; 1999 Jun; 8(2):92-6. PubMed ID: 10475383
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of genetic instabilities on chromosome loci 3, 6, 11, and 18 in human cervical carcinoma].
Zhao M; Wu XX
Ai Zheng; 2002 Jun; 21(6):640-3. PubMed ID: 12452066
[TBL] [Abstract][Full Text] [Related]
6. High resolution mapping of chromosome 6 deletions in cervical cancer.
Mazurenko N; Attaleb M; Gritsko T; Semjonova L; Pavlova L; Sakharova O; Kisseljov F
Oncol Rep; 1999; 6(4):859-63. PubMed ID: 10373671
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss and prognosis in carcinoma of the uterine cervix.
Kersemaekers AM; Kenter GG; Hermans J; Fleuren GJ; van de Vijver MJ
Int J Cancer; 1998 Aug; 79(4):411-7. PubMed ID: 9699535
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.
Bethwaite PB; Koreth J; Herrington CS; McGee JO
Br J Cancer; 1995 Apr; 71(4):814-8. PubMed ID: 7710949
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
11. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
13. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases.
Kersemaekers AM; van de Vijver MJ; Fleuren GJ
Int J Gynecol Pathol; 2000 Jul; 19(3):225-30. PubMed ID: 10907170
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
[TBL] [Abstract][Full Text] [Related]
16. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
[TBL] [Abstract][Full Text] [Related]
17. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
[TBL] [Abstract][Full Text] [Related]
18. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix.
Kersemaekers AM; van de Vijver MJ; Kenter GG; Fleuren GJ
Genes Chromosomes Cancer; 1999 Dec; 26(4):346-54. PubMed ID: 10534770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
